To Investigate the Effect of Esketamine Hydrochloride on Pulmonary Complications

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 102 participants.

Also called NCT06467513

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose other
Phase
Phase 4
Enrolled
  • 102 participants (planned count) (from the registry)
Sponsor
Zhang XIao Mei (from the registry)
Registry
  • NCT NCT06467513
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT06467513. Randomized; triple masking; primary purpose other. Start 2024-01-01 (actual); primary completion 2025-05 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
To Investigate the Effect of Esketamine Hydrochloride on Pulmonary Complications
Condition
Heart Diseases
Condition
Heart Valve Diseases
Intervention (Drug)
Esketamine hydrochloride injection
Lead sponsor
Zhang XIao Mei (class: other)

Record details

Record id
cardio:ct-nct06467513
Content hash
6def3ee340c057bf142070a38e8c35d612a69b61a4dde33e1a6f95b0f12a7f37